title: Skin testing and patch testing in non-IgE-mediated drug allergy.
abstract: Drug skin tests can reproduce delayed hypersensitivity to drugs and entail a moderate reexposure of patients to offending drugs. Drug patch tests (DPTs) and prick tests can be done with any commercialized form of a drug. In non-severe delayed non-IgE-mediated reactions to drugs, intradermal tests (IDT) with delayed readings have a greater value, but their techniques lack standardization. A negative drug skin test does not exclude the responsibility of a drug, and the drug must be rechallenged in non-severe cases. DPTs are useful in maculopapular rashes, flexural exanthemas, and if done in situ, also in fixed drug eruption. Their best indication is in acute generalized exanthematous pustulosis or drug reaction with eosinophilia and systemic symptoms (DRESS). They should be carried out cautiously, following strict guidelines. Prick tests have a low value but they can sometimes be positive on delayed readings. In non-severe delayed reactions to drugs, intradermal tests with delayed readings are the most sensitive skin tests especially for beta-lactam antibiotics, radiocontrast media, heparins but also some biological agents. The value of patch testing varies according to the implicated drug and the non-immediate adverse drug reaction. In DRESS, DPTs have a good value in testing carbamazepine or proton pump inhibitors but remain negative in testing with allopurinol or salazopyrin. In toxic epidermal necrolysis, DPTs are safe but positive in only 9 to 23 % of the reported cases.
authors.affiliation: Dermatology and Allergy department, University Hospital of Nancy, Pole des specialités medicales, Universite de Lorraine, Brabois Hospital, 6 rue du Morvan, Vandoeuvre les Nancy, 54500, France, a.barbaud@chu-nancy.fr.
authors.forename: Annick
authors.initials: A
authors.lastname: Barbaud
mesh_terms: D004342:Drug Hypersensitivity / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D009336:Necrosis; D010328:Patch Tests; D012882:Skin Tests
chemical_list: D007073:Immunoglobulin E
references.citation: Eur J Dermatol. 2013 Apr 1;23(2):135-41
references.pmid: 23238161
references.citation: Asian Pac J Allergy Immunol. 2011 Jun;29(2):150-60
references.pmid: 21980830
references.citation: Clin Exp Allergy. 2014;44(5):756-64
references.pmid: 24128045
references.citation: Immunol Allergy Clin North Am. 2009 Aug;29(3):517-35
references.pmid: 19563995
references.citation: Br J Dermatol. 2013 Mar;168(3):555-62
references.pmid: 23136927
references.citation: Contact Dermatitis. 2001 Dec;45(6):321-8
references.pmid: 11846746
references.citation: AIDS. 2008 May 31;22(9):999-1007
references.pmid: 18520343
references.citation: J Eur Acad Dermatol Venereol. 2008 Dec;22(12):1504-5
references.pmid: 18435739
references.citation: Eur J Dermatol. 2010 Jul-Aug;20(4):461-4
references.pmid: 20507840
references.citation: Contact Dermatitis. 2001 Nov;45(5):265-8
references.pmid: 11722484
references.citation: Contact Dermatitis. 2002 Aug;47(2):100-2
references.pmid: 12423408
references.citation: Contact Dermatitis. 1996 Oct;35(4):234-6
references.pmid: 8957644
references.citation: J Allergy Clin Immunol. 2007 Mar;119(3):726-30
references.pmid: 17258305
references.citation: Allergy. 2008 Jan;63(1):138-9
references.pmid: 18053024
references.citation: Br J Dermatol. 2009 Apr;160(4):786-94
references.pmid: 19120340
references.citation: Allergy. 2013 Aug;68(8):1057-64
references.pmid: 23889703
references.citation: Ann Dermatol Venereol. 2012 May;139(5):375-80
references.pmid: 22578342
references.citation: Contact Dermatitis. 2012 Feb;66(2):110-1
references.pmid: 22233474
references.citation: Int Arch Allergy Immunol. 2002 Oct;129(2):169-74
references.pmid: 12403935
references.citation: Acta Derm Venereol. 1970;50(4):287-92
references.pmid: 4195865
references.citation: Curr Pharm Des. 2008;14(27):2863-73
references.pmid: 18991704
references.citation: Allergy. 2009 Feb;64(2):234-41
references.pmid: 19178403
references.citation: Allergy. 2013 Jun;68(6):702-12
references.pmid: 23617635
references.citation: J Allergy Clin Immunol. 2012 Apr;129(4):1166-9
references.pmid: 22322006
references.citation: Br J Dermatol. 1987 Apr;116(4):561-7
references.pmid: 2953388
references.citation: J Allergy Clin Immunol. 2010 Jun;125(6):1410-1
references.pmid: 20338621
references.citation: J Eur Acad Dermatol Venereol. 2013 Mar;27(3):356-64
references.pmid: 22211830
references.citation: Allergy. 2002 Jan;57(1):45-51
references.pmid: 11991289
references.citation: Eur J Clin Pharmacol. 2012 Jan;68(1):101-5
references.pmid: 21792562
references.citation: Contact Dermatitis. 2010 Jan;62(1):47-53
references.pmid: 20136879
references.citation: Contact Dermatitis. 2011 Oct;65(4):195-201
references.pmid: 21702758
references.citation: Allergy. 2012 Jan;67(1):58-66
references.pmid: 21933197
references.citation: Allergy. 2009 Feb;64(2):183-93
references.pmid: 19133923